Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1970 2
1982 1
1986 2
1987 2
1988 2
1989 4
1990 4
1991 6
1992 4
1993 10
1994 7
1995 17
1996 9
1997 13
1998 14
1999 2
2000 10
2001 8
2002 8
2003 10
2004 7
2005 6
2006 6
2007 6
2008 7
2009 7
2010 10
2011 22
2012 12
2013 19
2014 12
2015 8
2016 11
2017 12
2018 14
2019 18
2020 20
2021 33
2022 19
2023 35
2024 15
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Results by year

Filters applied: . Clear all
Page 1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. Among authors: kataoka a. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Free PMC article. Clinical Trial.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.
Horisawa N, Adachi Y, Takatsuka D, Nozawa K, Endo Y, Ozaki Y, Sugino K, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Horisawa N, et al. Among authors: kataoka a. Breast Cancer. 2022 Mar;29(2):234-241. doi: 10.1007/s12282-021-01303-3. Epub 2021 Oct 7. Breast Cancer. 2022. PMID: 34622383
P2Y(6)-Evoked Microglial Phagocytosis.
Inoue K, Koizumi S, Kataoka A, Tozaki-Saitoh H, Tsuda M. Inoue K, et al. Among authors: kataoka a. Int Rev Neurobiol. 2009;85:159-63. doi: 10.1016/S0074-7742(09)85012-5. Int Rev Neurobiol. 2009. PMID: 19607968 Review.
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
Azim HA Jr, Niman SM, Partridge AH, Demeestere I, Ruggeri M, Colleoni M, Saura C, Shimizu C, Saetersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Klar NJ, Spanic T, Ruddy K, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O, Peccatori FA. Azim HA Jr, et al. Among authors: kataoka a. J Clin Oncol. 2024 Aug 10;42(23):2822-2832. doi: 10.1200/JCO.23.02292. Epub 2024 May 29. J Clin Oncol. 2024. PMID: 38810178
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.
Isogai A, Nozawa K, Nakakami A, Komaki R, Ozaki Y, Endo Y, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Isogai A, et al. Among authors: kataoka a. Breast Cancer Res Treat. 2024 Sep;207(2):253-261. doi: 10.1007/s10549-024-07367-x. Epub 2024 May 26. Breast Cancer Res Treat. 2024. PMID: 38797792
Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study.
Nakata A, Hashimoto N, Narita Y, Wakabayashi M, Kodama H, Ogata T, Honda K, Masuishi T, Taniguchi H, Kadowaki S, Ando M, Endo Y, Kotani H, Kataoka A, Hattori M, Yoshimura A, Sawaki M, Nozawa K, Oze I, Iwata H, Muro K. Nakata A, et al. Among authors: kataoka a. Oncologist. 2024 Sep 11:oyae223. doi: 10.1093/oncolo/oyae223. Online ahead of print. Oncologist. 2024. PMID: 39265970 Free article.
Bat Influenza A(HL18NL11) Virus in Fruit Bats, Brazil.
Campos ACA, Góes LGB, Moreira-Soto A, de Carvalho C, Ambar G, Sander AL, Fischer C, Ruckert da Rosa A, Cardoso de Oliveira D, Kataoka APG, Pedro WA, Martorelli LFA, Queiroz LH, Cruz-Neto AP, Durigon EL, Drexler JF. Campos ACA, et al. Among authors: kataoka apg. Emerg Infect Dis. 2019 Feb;25(2):333-337. doi: 10.3201/eid2502.181246. Emerg Infect Dis. 2019. PMID: 30666923 Free PMC article.
392 results